The Board proposes the development of rule amendments to clarify the continuing education requirements for biennial renewal and to set forth the approved controlled substance prescribing courses for biennial renewal.

 

DEPARTMENT OF HEALTH

Board of Osteopathic Medicine

RULE NO.: RULE TITLE:

64B15-13.001 Continuing Education for Biennial Renewal

PURPOSE AND EFFECT: The Board proposes the development of rule amendments to clarify the continuing education requirements for biennial renewal and to set forth the approved controlled substance prescribing courses for biennial renewal.

SUBJECT AREA TO BE ADDRESSED: Clarification of continuing education requirements and approved controlled substance prescribing courses for biennial renewal.

RULEMAKING AUTHORITY: 456.013, 456.0301, 459.005, 459.008(4) FS.

LAW IMPLEMENTED: 456.013, 456.0301, 456.031, 459.008 FS.

IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Kama Monroe, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.

 

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.